| 1995 |
COX14 encodes a low molecular mass protein (~8 kDa) that localizes to the mitochondrial membrane and is associated with a high molecular weight complex; loss of COX14 results in a cytochrome oxidase assembly-arrested phenotype despite normal synthesis of mitochondrially encoded COX subunits, establishing COX14 as a COX assembly factor acting at a late stage of the pathway. |
Complementation cloning, Western analysis, biotinylated gene fusion localization, cytochrome oxidase activity assay |
The Journal of biological chemistry |
High |
7797555
|
| 2004 |
Cox14p and Mss51p (a COX1 mRNA translational activator) interact with each other and with newly synthesized Cox1p to form a transient Cox14p–Cox1p–Mss51p assembly intermediate complex; this complex functions to downregulate Cox1p synthesis (sequestering Mss51p), and deletion of COX14 alone does not reduce Cox1p synthesis because the sequestration complex fails to form. |
Co-immunoprecipitation, pulse-labeling of mitochondrial translation products, genetic epistasis (cox14 null combined with other COX mutants and mss51 suppressor mutations) |
The EMBO journal |
High |
15306853
|
| 2007 |
Shy1 (yeast SURF1 ortholog) interacts with Mss51 and Cox14 in translational regulatory complexes and also associates with later COX assembly subcomplexes; Cox14-containing partially assembled COX complexes can associate with the bc1 complex to form transitional supercomplexes, linking Cox1 translational regulation to supercomplex formation. |
Co-immunoprecipitation, native gel electrophoresis (BN-PAGE), affinity purification, mass spectrometry |
The EMBO journal |
High |
17882259
|
| 2009 |
Mss51 does not stably interact with newly synthesized Cox1 in a cox14 null mutant, demonstrating that Cox14 is required for sequestration of Mss51 in early COX assembly intermediates; the Mss51–Cox14 physical interaction depends on the presence of newly synthesized Cox1, indicating dynamic assembly of Cox1-nucleated early intermediates. |
Co-immunoprecipitation of newly synthesized Cox1, pulse-labeling, ARG8m reporter assay for translational output |
Molecular biology of the cell |
High |
19710419
|
| 2010 |
Coa3 and Cox14 together form early COX assembly intermediates with newly synthesized Cox1 and are both required for Mss51 association with these complexes; Mss51 exists in equilibrium between a latent (translational resting) state and a committed (translation-effective) state represented as distinct complexes, and Coa3/Cox14 promote formation of the latent state to downregulate COX1 expression; Coa1 binding to Mss51 in complex with Cox14, Coa3, and Cox1 is essential for full Mss51 inactivation. |
Co-immunoprecipitation, pulse-labeling, BN-PAGE, identification of novel assembly factor Coa3 (Yjl062w-A) by mass spectrometry |
The Journal of cell biology |
High |
20876281
|
| 2010 |
Deletion of the C-terminal 11 or 15 residues of Cox1 eliminates assembly-feedback control of Cox1 synthesis and reduces the strength of the Mss51–Cox14 interaction, establishing that the Cox1 C-terminal domain is required for Mss51 sequestration via Cox14 in early assembly intermediates. |
Site-directed mutagenesis of mtDNA, co-immunoprecipitation, pulse-labeling, ARG8m reporter assay |
The Journal of biological chemistry |
High |
20807763
|
| 2010 |
Cox25 is an inner mitochondrial membrane protein that is an essential component of the Cox1–Ssc1–Mss51–Cox14 early assembly complex; after Ssc1–Mss51 release, Cox25 continues to interact with Cox14 and Cox1 to facilitate formation of multisubunit COX assembly intermediates and also interacts with Shy1 and Cox5 in a separate Mss51-free complex. |
Co-immunoprecipitation, BN-PAGE, pulse-labeling, genetic epistasis (cox25 null phenotype) |
The Journal of biological chemistry |
High |
21068384
|
| 2012 |
C12orf62 (human ortholog of yeast COX14, also called COX14 in humans) is a small (~6 kDa) single-transmembrane protein that localizes to mitochondria, co-immunoprecipitates with COX I, COX II, and COX IV, and is required for coupling early COX assembly steps with COX I synthesis; loss-of-function mutations cause COX-assembly defects with specific decrease in COX I synthesis and fatal neonatal lactic acidosis. |
Microcell-mediated chromosome transfer, homozygosity mapping, siRNA knockdown, retroviral rescue, co-immunoprecipitation with epitope-tagged C12orf62, 2D BN-PAGE of newly synthesized subunits, immunoblot |
American journal of human genetics |
High |
22243966
|
| 2012 |
Iterative orthology prediction (Ortho-Profile) confirmed that human C12orf62 is the functional ortholog of yeast COX14; experimental validation of subcellular localization to mitochondria and co-purification with human COX-associated proteins confirmed its role in negative regulation of COX I translation. |
Bioinformatic orthology prediction validated by experimental co-purification and localization studies |
Genome biology |
Medium |
22356826
|
| 2015 |
COX14 (C12orf62) and COA3 are mutually interdependent for their stability: COX14 protein is undetectable in COA3-deficient patient fibroblasts and COA3 is undetectable in COX14-deficient fibroblasts, demonstrating that they form a co-dependent early COX assembly complex containing COX1. |
Immunoblot analysis of patient fibroblasts with COA3 or COX14 mutations, BN-PAGE, pulse-labeling, retroviral rescue |
Journal of medical genetics |
High |
25604084
|
| 2016 |
Human mitochondrial ribosomes translating COX1 mRNA selectively engage with cytochrome c oxidase assembly factors (including COX14) in the inner membrane; COX assembly defects arrest mitochondrial translation in a ribosome–nascent chain complex with partially membrane-inserted COX1, establishing a translational plasticity pathway in which COX14 participates in coupling synthesis to assembly. |
Ribosome nascent chain complex isolation, BN-PAGE, quantitative mass spectrometry (SILAC), siRNA knockdown, pulse-labeling |
Cell |
High |
27693358
|
| 2017 |
CMC1 forms an early COX assembly intermediate with COX1, COA3, and COX14; CMC1 knockout shows normal COX1 synthesis but decreased COX activity due to instability of newly synthesized COX1, and CMC1 stabilizes the COX1–COA3–COX14 complex prior to incorporation of COX4 and COX5a; CMC1 acts independently of COX10, COX11, SURF1 (metallation/late stability factors), indicating a distinct role for the COX14-containing early complex. |
TALEN-mediated knockout, BN-PAGE, co-immunoprecipitation, pulse-labeling, immunoblot |
EMBO reports |
High |
28082314
|
| 2017 |
Cox1 C-terminal mutations (P521A/P522A and V524E) disrupt the regulatory role of the Cox1 C-terminus by reducing binding of Mss51 and Cox14 to COA complexes, enriching Mss51 in a translationally active form and maintaining full Cox1 synthesis even when COX assembly is blocked; this confirms that the Cox1 C-terminal domain directly mediates the Mss51–Cox14 interaction within assembly intermediates. |
Site-directed mutagenesis of mitochondrial COX1 gene, co-immunoprecipitation, BN-PAGE, pulse-labeling |
The Journal of biological chemistry |
High |
28490636
|
| 2017 |
Mitospecific ribosomal protein MrpL35, together with Mrp7, coordinates Cox1 synthesis with COX assembly in a manner requiring Cox14 and Coa3, indicating that the mitoribosome communicates with the Cox14/Coa3 early assembly module. |
Genetic analysis of mrpL35 mutants, co-immunoprecipitation, pulse-labeling, epistasis with cox14 deletion |
Molecular biology of the cell |
Medium |
28931599
|
| 2024 |
A COX14 M19I missense mouse model corresponding to a human complex IV deficiency patient shows that COX14 is required for COX1 translation in vivo; loss of COX14 function triggers release of mitochondrial RNA into the cytosol (sensed by the RIG-1 pathway), driven by increased reactive oxygen species from complex IV deficiency, leading to tissue-specific liver inflammation. |
COX14 M19I knock-in mouse model, pulse-labeling of mitochondrial translation, ROS measurements, cytosolic mtRNA detection, RIG-1 pathway activation assays, comparison with COA3 Y72C mouse model |
Nature communications |
High |
39134548
|